Matulac, Rogelio B.

HRN: 22-02-48  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
MUPIROCIN 2%, 15G (TUBE)
10/30/2022
11/05/2022
TOPICAL
1mg
BID
Bed Sores And Superficial Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: